Andre Luiz Leturiondo
Overview
Explore the profile of Andre Luiz Leturiondo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
62
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Grana A, Chirano C, Talhari S, de Sousa D, de Souza L, Leturiondo A, et al.
Int J Dermatol
. 2025 Jan;
PMID: 39846086
Background: Active case-finding is an effective strategy for combating leprosy, especially in early multibacillary cases in endemic regions. This early approach includes systematic actions such as epidemiological investigations, community surveys,...
2.
de Souza G, de Brito E, de Lima Fernandes D, Frota M, de Araujo Santos F, de Oliveira Ferreira C, et al.
Trop Med Int Health
. 2024 Dec;
30(1):65-69.
PMID: 39628138
Background: Sporotrichosis is a neglected tropical disease and the most common subcutaneous mycosis, mainly caused by Sporothrix species, particularly S. brasiliensis, S. schenckii and S. globosa, which exhibit varying biological...
3.
Mesquita V, Talhari S, Leturiondo A, de Souza G, de Brito E, de Andrade S, et al.
PLoS Negl Trop Dis
. 2024 Jul;
18(7):e0012328.
PMID: 39038043
Background: Sporotrichosis is the most common subcutaneous mycosis caused by Sporothrix spp. Traditionally, it is transmitted through injuries involving plant debris. However, over the past few decades, there has been...
4.
Pennini S, Guerra J, Rebello P, Abtibol-Bernardino M, de Castro L, Balieiro A, et al.
Trop Med Int Health
. 2023 Nov;
28(12):871-880.
PMID: 37936525
Objective: To determine whether a combination of a single intramuscular (IM) dose of pentamidine (7 mg/kg) followed by oral tamoxifen 40 mg/day for 20 days is non-inferior to three IM...
5.
Leturiondo A, Noronha A, Mendonca C, de Oliveira Ferreira C, Alvarado-Arnez L, Manta F, et al.
PLoS Negl Trop Dis
. 2023 Mar;
17(3):e0011228.
PMID: 36961805
[This corrects the article DOI: 10.1371/journal.pntd.0008247.].
6.
Bezerra O, Alvarado-Arnez L, Mabunda N, Salome G, de Sousa A, Kehdy F, et al.
PLoS Negl Trop Dis
. 2021 Aug;
15(8):e0009434.
PMID: 34449765
Pyruvate kinase (PK), encoded by the PKLR gene, is a key player in glycolysis controlling the integrity of erythrocytes. Due to Plasmodium selection, mutations for PK deficiency, which leads to...
7.
Bezerra N, Schettini A, Leturiondo A, Mathias L
An Bras Dermatol
. 2020 Dec;
96(1):97-99.
PMID: 33288364
Leprosy is a chronic infectious disease caused by Mycobacterium leprae and, depending on the host immune status, presents different clinical forms. This report describes the case of a 46-year-old man...
8.
Leturiondo A, Noronha A, Mendonca C, de Oliveira Ferreira C, Alvarado-Arnez L, Manta F, et al.
PLoS Negl Trop Dis
. 2020 May;
14(5):e0008247.
PMID: 32433683
Leprosy is a chronic infectious disease, caused by Mycobacterium leprae, which affects skin and peripheral nerves. Polymorphisms in genes associated with autophagy, metabolism, innate and adaptive immunity confer susceptibility to...
9.
Leturiondo A, Noronha A, do Nascimento M, de Oliveira Ferreira C, Rodrigues F, Moraes M, et al.
BMC Infect Dis
. 2019 Jan;
19(1):22.
PMID: 30616580
Background: Early detection of leprosy and multidrug therapy are crucial to achieve zero transmission and zero grade II incapacities goals of World Health Organization. Leprosy is difficult to diagnose because...
10.
Teixeira M, Sabido M, Leturiondo A, de Oliveira Ferreira C, Torres K, Benzaken A
Virol J
. 2018 Feb;
15(1):36.
PMID: 29454382
Background: Human immunodeficiency virus (HIV)-positive women have a high prevalence of human papillomavirus (HPV), and are infected with a broader range of HPV types than HIV-negative women. We aimed to...